WO2022219528A1 - Tissue removing catheter with tissue-removing element having oblique distal end face - Google Patents
Tissue removing catheter with tissue-removing element having oblique distal end face Download PDFInfo
- Publication number
- WO2022219528A1 WO2022219528A1 PCT/IB2022/053424 IB2022053424W WO2022219528A1 WO 2022219528 A1 WO2022219528 A1 WO 2022219528A1 IB 2022053424 W IB2022053424 W IB 2022053424W WO 2022219528 A1 WO2022219528 A1 WO 2022219528A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- tissue
- removing element
- distal end
- set forth
- central axis
- Prior art date
Links
- 210000004204 blood vessel Anatomy 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 230000003902 lesion Effects 0.000 claims description 11
- 230000008878 coupling Effects 0.000 claims description 8
- 238000010168 coupling process Methods 0.000 claims description 8
- 238000005859 coupling reaction Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 238000002679 ablation Methods 0.000 description 2
- 239000003082 abrasive agent Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000007887 coronary angioplasty Methods 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 206010020718 hyperplasia Diseases 0.000 description 2
- 230000002390 hyperplastic effect Effects 0.000 description 2
- 230000002966 stenotic effect Effects 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 229920006335 epoxy glue Polymers 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 230000009826 neoplastic cell growth Effects 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 210000000277 pancreatic duct Anatomy 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000013151 thrombectomy Methods 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 210000000626 ureter Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
- A61B17/3207—Atherectomy devices working by cutting or abrading; Similar devices specially adapted for non-vascular obstructions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/32—Surgical cutting instruments
- A61B2017/320004—Surgical cutting instruments abrasive
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/08—Accessories or related features not otherwise provided for
- A61B2090/0801—Prevention of accidental cutting or pricking
- A61B2090/08021—Prevention of accidental cutting or pricking of the patient or his organs
Definitions
- the present disclosure generally relates to a tissue-removing catheter, and more particularly, to tissue-removing catheter including a rotatable tissue-removing element having an oblique distal end face.
- Tissue-removing catheters are used to remove unwanted tissue in body lumens.
- atherectomy catheters are used to remove material from a blood vessel to open the blood vessel and improve blood flow through the vessel. This process can be used to prepare lesions within a patient's coronary artery to facilitate percutaneous coronary angioplasty (PTCA) or stent delivery in patients with severely calcified coronary artery lesions.
- Atherectomy catheters may employ a rotating element which is used to abrade or otherwise debulk the unwanted tissue.
- a tissue-removing catheter for removing tissue in a body lumen comprises an elongate catheter body having a longitudinal axis and proximal and distal end portions spaced apart from one another along the longitudinal axis.
- the elongate catheter body is sized and shaped to be received in the body lumen.
- a tissue-removing element is operatively coupled to the distal end portion of the elongate catheter body.
- the tissue-removing element has a central axis and proximal and a distal end portions spaced apart from one another along the central axis of the tissue-removing element.
- the tissue- removing element is configured to be rotated about its central axis to remove tissue from the body lumen.
- the distal end portion of the tissue-removing element includes a distal end face at a distal-most end of the tissue-removing element.
- the distal end face has a perimeter and a diameter extending through the central axis. Diametrically opposite points on the perimeter lie in a plane that is oblique to the central axis of the tissue-removing element.
- a tissue-removing catheter for removing tissue in a body lumen comprises an elongate catheter body having a longitudinal axis and proximal and distal end portions spaced apart from one another along the longitudinal axis.
- the elongate catheter body is sized and shaped to be received in the body lumen.
- a tissue- removing element is operatively coupled to the distal end portion of the elongate catheter body.
- the tissue-removing element has a central axis and proximal and a distal end portions spaced apart from one another along the central axis of the tissue-removing element.
- the tissue-removing element is configured to be rotated to remove tissue from the body lumen.
- the distal end portion of the tissue-removing element includes a distal end face at a distal-most end of the tissue-removing element.
- the distal end face has a perimeter extending around the opening and a diameter extending through the axis of the distal opening. Diametrically opposite points on the perimeter lie in a plane that is oblique to the central axis of the tissue-removing element.
- a distal opening extends through the distal end face.
- the distal opening in the distal end face has an axis.
- a method of debulking a lesion in a blood vessel using a rotational atherectomy catheter comprises advancing a tissue-removing element of the rotational atherectomy catheter toward the lesion in the blood vessel.
- the tissue-removing element has a central axis and proximal and a distal end portions spaced apart from one another along the central axis of the tissue-removing element.
- the distal end portion of the tissue-removing element includes a distal end face at a distal-most end of the tissue-removing element.
- the distal end face has a perimeter and a diameter extending through the central axis. Diametrically opposite points on the perimeter he in a plane that is oblique to the central axis of the tissue-removing element.
- the tissue-removing element is rotated about its central axis simultaneously with said advancing rotational atherectomy catheter through the blood vessel, whereby rotation of the oblique distal end face of the tissue-removing element is configured to facilitate release of the tissue-removing element if the distal end face engages an obstruction in the blood vessel as the rotational atherectomy catheter is advanced in the blood vessel.
- FIG. 1 is an elevation of a tissue-removing catheter of the present invention
- FIG. 2 is an enlarged elevation of a distal end portion of the catheter
- FIG. 3 is an enlarged fragmentary longitudinal cross section of the distal end portion of the catheter in FIG. 2;
- FIG. 4 is a schematic representation of a tissue-removing element of the tissue- removing catheter in engagement with an obstruction within a body lumen;
- FIG. 5 is similar to FIG. 4, showing the tissue-removing element rotating around the obstruction.
- FIG. 6 is similar to FIG. 4, showing the tissue-removing element bypassing the obstruction.
- FIG. 7 is another embodiment of a tissue-removing element.
- FIG. 8 is yet another embodiment of a tissue-removing element.
- a rotational tissue-removing catheter for removing tissue in a body lumen is generally indicated at reference number 10.
- the illustrated catheter 10 is a rotational atherectomy device suitable for debulking (e.g., abrading, cutting, excising, ablating, etc.) occlusive tissue (e.g., embolic tissue, plaque tissue, atheroma, thrombolytic tissue, stenotic tissue, hyperplastic tissue, neoplastic tissue, etc.) from a vessel wall (e.g., coronary arterial wall, etc.).
- the catheter 10 may be used to facilitate percutaneous coronary angioplasty PTCA or the subsequent delivery of a stent.
- CTO chronic total occlusion
- Other body lumens such as a ureter, a biliary duct, respiratory passages, the pancreatic duct, the lymphatic duct, and the like.
- Neoplastic cell growth will often occur as a result of a tumor surrounding and intruding into a body lumen. Removal of such material can thus be beneficial to maintain patency of the body lumen.
- the illustrated catheter 10 is sized for being received in a blood vessel of a subject. While the remaining discussion is directed toward a catheter for removing tissue in blood vessels, it will be appreciated that the teaching of the present disclosure also applies to other types of tissue-removing catheters, including, but not limited to, catheters for penetrating and/or removing tissue from a variety of occlusive stenotic, or hyperplastic material in a variety of body lumens.
- the catheter 10 comprises a catheter body, generally indicated at 11.
- the catheter body 11 includes an elongate drive shaft 12 and an elongate inner liner 14 received in an extending along the drive shaft.
- the drive shaft 12 and inner liner 14 extend along a longitudinal axis LA of the catheter body from a proximal end portion to a distal end portion of the catheter body.
- a tissue-removing element 20 is operatively coupled to a distal end of the drive shaft 12 and is configured for rotation to remove tissue from a body lumen, as will be explained in greater detail below.
- the drive shaft 12 may include a coiled elongate body, which may be formed from stainless steel or other material.
- a sheath 22 is disposed around the drive shaft 12.
- the drive shaft 12 and the inner liner 14 are both configured to translate (i.e., move longitudinally) relative to the sheath 22.
- the catheter body 11 and the sheath 22 are sized and shaped for insertion into a body lumen of a subject.
- the sheath 22 isolates the body lumen from at least a portion of the catheter body 11, and more particularly, at least a portion of the drive shaft 12.
- the inner liner 14 defines a guidewire lumen 24 (FIG. 3) for slidably receiving a guidewire 26 therein so that the catheter body 11 can be advanced through the body lumen by traveling along the guidewire.
- the guidewire 26 can be a standard 0.014 inch (0.356 mm) outer diameter, 300 cm length guidewire.
- the inner liner 14 may have a lubricious inner surface for sliding over the guidewire 26 (e.g., a lubricious surface may be provided by a lubricious polymer layer or a lubricious coating).
- the guidewire lumen 24 extends from the proximal end portion through the distal end portion of the catheter body 11 such that the guidewire 26 is extendable along an entire working length of the catheter body.
- the overall working length of the catheter 10 may be between about 135 cm (53 inches) and about 142 cm (56 inches).
- the inner liner 14 protects the guidewire 26 from being damaged from rotation of the drive shaft 12 by isolating the guidewire from the rotating drive shaft.
- the illustrated inner liner 14 also extends distally through the tissue-removing element 20 so that the distal end of the inner liner is exposed outside the tissue-removing element to protect the guidewire 26 from the rotating tissue-removing element. [0019] Referring to FIG.
- the catheter 10 further comprises a handle 40 secured at the proximal end portion of the catheter body.
- the handle 40 supports an actuator 42 (e.g., a lever, a button, a dial, a switch, or other device) configured to selectively actuate a drive, for example a motor 43, disposed in the handle to drive rotation of the drive shaft 12, and the tissue-removing element 20.
- a drive for example a motor 43, disposed in the handle to drive rotation of the drive shaft 12, and the tissue-removing element 20.
- the motor 43 is coupled to the drive shaft 12 by a gear assembly 44 and an output shaft 48 supported by the handle 40.
- a slide or advancer 45 is positioned on the handle 40 and operatively coupled to the drive 43 to enable selective longitudinal advancement and retraction of the drive 43, the drive shaft 12, and tissue-removing element 20 relative to the handle 40 and the sheath 22.
- the handle 40 defines a slot which limits the movement of the slide 45 relative to the handle. Thus, the length of the slot determines the amount of relative movement between the drive shaft 12 and the handle 40.
- a perfusion port 46 may be disposed at the proximal end of the catheter 10. The port 46 communicates with a space between the sheath 22 and the drive shaft 12 for delivering fluid (e.g., saline) to cool the rotating drive shaft 12 during use.
- a proximal port 47 allows for passage of the guidewire 26 and inner liner 14 through the proximal end of the handle 40.
- a guidewire lock (not shown) may be provided on the handle 40 to lock the guidewire 26 in place relative to the handle, which may be desired during rotation of the tissue-removing element 20 to remove unwanted tissue in the body lumen.
- a drive shaft adaptor 88 couples the tissue-removing element 20 to the drive shaft 12 to transmit rotation from the drive shaft to the tissue-removing element.
- the drive shaft adaptor 88 is fixedly secured (e.g., welded) to a proximal end portion of the tissue-removing element 20 and fixedly secured (e.g., welded) to a distal end portion of the drive shaft 12. It is understood that the drive shaft 12 may be directly coupled to the tissue-removing element 20.
- the catheter 10 includes a coupling assembly, generally indicated at 57, coupling the tissue-removing element 20 to the inner liner 14.
- the illustrated coupling assembly 57 includes a bushing 90 and bearing rings (e.g., first and second bearing rings 98, 99) received around the bushing 90.
- An interior surface of the bushing 90 is fixedly attached to the inner liner 14.
- an adhesive such as an epoxy glue bonds the bushing 90 to the inner liner 14.
- the first and second bearing rings 98, 99 are coupled to the tissue-removing element 20 and/or the drive shaft adaptor 88.
- the bearing rings 98, 99 ride on the bushing 90 as the tissue-removing element 20 rotates.
- the first and second bearing rings 98, 99 are configured to engage a shoulder 94 of the bushing 90 so that translational movement of the drive shaft 12 is transmitted to the bushing 90 and the inner liner 14.
- the coupling assembly 57 isolates the tissue-removing element 20 from the inner liner 14 and is configured to enable rotation of the tissue-removing element about the inner liner. It is understood that the coupling assembly 57 may be omitted so that the tissue-removing element rotates directly on a guidewire or an inner liner.
- the tissue-removing element 20 has a central axis CA1 and proximal and distal end portions spaced apart from one another along the central axis. As described above, the tissue-removing element 20 is operatively coupled to the distal end portion of the catheter body, and more specifically the drive shaft 12 in the illustrated embodiment. Rotation of the drive shaft 12 by the drive 43 imparts rotation of the tissue- removing element 20 about the central axis CA1 to remove tissue from the body lumen.
- the central axis CA1 is aligned with the longitudinal axis LA of the catheter body 11. Also in the illustrated embodiment, the central axis CA1 is coextensive with longitudinal axes of the inner liner 14 and/or the bushing 90 and/or the guidewire 26 (when the guidewire is received in the inner liner).
- the illustrated tissue- removing element 20 comprises an abrasive outer surface configured to abrade tissue in the body lumen when the motor 43 rotates the abrasive burr. Thus, the illustrated tissue- removing element 20 may be considered an abrasive burr.
- the abrasive outer surface is formed, for example, by a diamond grit coating, surface etching, or the like.
- the tissue-removing element 20 can compromise one or more cutting elements having smooth or serrated cutting edges, a macerator, a thrombectomy wire, etc.
- the tissue-removing element may be of other configurations and designs for suitably removing tissue in the body lumen as it is rotated.
- the distal end portion of the tissue-removing element 20 includes a distal end face 100 at a distal -most end of the tissue-removing element.
- the illustrated distal end portion of the tissue-removing element 20 is generally cone-shaped (e.g., truncated cone-shaped) having an outer diameter that tapers distally to the distal end face 100.
- the distal end face has a perimeter and a diameter extending through the central axis CA1. At least some diametrically opposite points on the perimeter lie in a plane PI that is oblique to the central axis CA1 of the tissue-removing element 20.
- all diametrically opposite points on the perimeter lie in the plane P 1 that is oblique to the central axis CA1 of the tissue-removing element 20.
- the plane PI may intersect a plane OP1 orthogonal to the central axis CA1 at an angle A1 measuring from about 5 degrees to about 45 degrees, or from about 10 degrees to about 30 degrees.
- the plane PI may intersect the orthogonal plane OP1 at an angle A1 of about 5 degrees, or 10 degrees, or 15 degrees, or 25 degrees, or 30 degrees, or 40 degrees, or 45 degrees.
- the angle A1 may measure about 10 degrees.
- the proximal end portion of the tissue-removing element 20 is generally symmetrical about the central axis CA1.
- tissue-removing element 20 that is proximal of a proximal portion of the distal end face 100 is symmetrical circumferentially about the central axis CA1.
- the tissue-removing element 20 may be generally symmetrical circumferentially about the central axis CA1.
- the distal end face 100 is generally planer and oblique (e.g., beveled), and lies in the plane PI that is oblique to the central axis CA1 of the tissue-removing element 20.
- the distal end face 100 is free from abrasive material, although the distal end face may include abrasive material.
- the plane PI in which the distal end face 100 lies may intersect a plane OP1 orthogonal to the central axis CA1 at an angle A1 measuring from about 5 degrees to about 45 degrees, or from about 10 degrees to about 30 degrees.
- the plane PI may intersect the orthogonal plane OP at an angle A of about 5 degrees, or 10 degrees, or 15 degrees, or 25 degrees, or 30 degrees, or 40 degrees, or 45 degrees.
- the angle A1 may measure about 10 degrees.
- a distal opening 102 of the tissue-removing element 20 extends through the distal end face 100 such that the distal end face extends circumferentially about the distal opening.
- the central axis CA1 of the tissue-removing element 20 is coextensive with the axis of the distal opening 102 such that the distal end face 100 is oblique to the axis of the distal opening.
- a distal end portion of the inner liner 14 and/or a distal end portion of the bearing 90 extends through the distal opening 102.
- the guidewire 26 is extendable through the distal opening 102 as it extends along the inner liner 14.
- the tissue-removing element 20 is configured to rotate concentrically about the guidewire when the guidewire is received in the inner liner 14.
- one or both of the inner liner 14 and the bushing 90 may not extend through the distal opening 102.
- one or both of the inner liner 14 and the bushing 90 may be omitted from the catheter 10, whereby the guidewire 26 may extend directly through the distal opening 102.
- the catheter body 12 is inserted into the body lumen (e.g., a blood vessel, such as an artery) to deliver the tissue- removing element 20 to the lesion or other tissue to be removed.
- the tissue-removing element 20 may encounter an obstruction or "hang-up" on the wall of the body lumen, as shown in FIG. 4. It is desired to move the tissue-removing element 20 pass the obstruction in an efficient manner.
- the oblique distal end face 100 facilitates this bypassing movement.
- the tissue-removing element 20 can be rotated as it is tracked along the body lumen.
- the tissue-removing element 20 may be rotated continuously or in discrete increments as it is tracked along the body lumen.
- the tissue-removing element 20 rotates away from the obstruction because of the rotating oblique distal end face which functions similar to a cam movement.
- the instability of contact between the distal end face 100 and the obstruction reduces the potential hang ups.
- the tissue-removing element 20 efficiently bypasses the obstruction.
- the oblique distal end face 100 may also improve the centering of the tissue-removing element 20 for ablation and lesion entry, along with potentially reducing the risk of the burr jumping forward on lesion breakthrough.
- the oblique distal end face 100 can also prevent the burr from burrowing into a "false lumen.”
- a distal end face 200 of another tissue-removing element 220 is convex, such that the distal end face is not generally planar.
- the distal end face 200 has a perimeter and a diameter extending through the central axis CA2. At least some diametrically opposite points on the perimeter lie in a plane P2 that is oblique to the central axis CA2 of the tissue-removing element 220. In this and other embodiments, all diametrically opposite points on the perimeter he in the plane P2 that is oblique to the central axis CA2 of the tissue-removing element 220.
- the plane P2 may intersect a plane OP2 orthogonal to the central axis CA2 at an angle A2 measuring from about 5 degrees to about 45 degrees, or from about 10 degrees to about 30 degrees.
- the plane P2 may intersect the orthogonal plane OP2 at an angle A2 of about 5 degrees, or 10 degrees, or 15 degrees, or 25 degrees, or 30 degrees, or 40 degrees, or 45 degrees.
- the angle A2 may measure about 10 degrees.
- the proximal end portion of the tissue-removing element 220 is generally symmetrical about the central axis CA2.
- tissue-removing element 220 that is proximal of a proximal portion of the distal end face 200 is symmetrical circumferentially about the central axis CA2.
- the tissue-removing element 220 may be generally symmetrical circumferentially about the central axis CA2.
- the tissue-removing element 20 may be incorporated into the rotational tissue-removing catheter 10. The use and benefit of the tissue-removing element 220 may be similar to the first tissue-removing element 20.
- a distal end face 300 of another tissue-removing element 320 is convex, such that the distal end face is not generally planar.
- the distal end face 300 has a perimeter and a diameter extending through the central axis CA3. At least some diametrically opposite points on the perimeter he in a plane P3 that is oblique to the central axis CA3 of the tissue-removing element 320. In this and other embodiments, all diametrically opposite points on the perimeter he in the plane P3 that is oblique to the central axis CA3 of the tissue-removing element.
- the plane P3 may intersect a plane OP3 orthogonal to the central axis CA3 at an angle A3 measuring from about 5 degrees to about 45 degrees, or from about 10 degrees to about 30 degrees.
- the plane P3 may intersect the orthogonal plane OP3 at an angle A3 of about 5 degrees, or 10 degrees, or 15 degrees, or 25 degrees, or 30 degrees, or 40 degrees, or 45 degrees.
- the angle A3 may measure about 10 degrees.
- the proximal end portion of the tissue-removing element 320 is generally symmetrical about the central axis CA3.
- tissue-removing element 320 that is proximal of a proximal portion of the distal end face 300 is symmetrical circumferentially about the central axis CA3.
- the tissue-removing element 320 may be generally symmetrical circumferentially about the central axis CA3.
- the tissue-removing element 220 may be incorporated into the rotational tissue-removing catheter 10.
- the use and benefit of the tissue-removing element 320 may be similar to the first tissue-removing element 20.
- the described techniques may be implemented in hardware, software, firmware, or any combination thereof. If implemented in software, the functions may be stored as one or more instructions or code on a computer-readable medium and executed by a hardware-based processing unit.
- Computer-readable media may include non-transitory computer-readable media, which corresponds to a tangible medium such as data storage media (e.g., RAM, ROM, EEPROM, flash memory, or any other medium that can be used to store desired program code in the form of instructions or data structures and that can be accessed by a computer).
- processors such as one or more digital signal processors (DSPs), general purpose microprocessors, application specific integrated circuits (ASICs), field programmable logic arrays (FPGAs), or other equivalent integrated or discrete logic circuitry.
- DSPs digital signal processors
- ASICs application specific integrated circuits
- FPGAs field programmable logic arrays
- processors may refer to any of the foregoing structure or any other physical structure suitable for implementation of the described techniques. Also, the techniques could be fully implemented in one or more circuits or logic elements.
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Surgical Instruments (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP22717920.7A EP4322873A1 (en) | 2021-04-12 | 2022-04-12 | Tissue removing catheter with tissue-removing element having oblique distal end face |
CN202280036985.6A CN117355268A (en) | 2021-04-12 | 2022-04-12 | Tissue-removing catheter including tissue-removing element having beveled distal surface |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163173597P | 2021-04-12 | 2021-04-12 | |
US63/173,597 | 2021-04-12 | ||
US17/711,522 US20220323098A1 (en) | 2021-04-12 | 2022-04-01 | Tissue Removing Catheter with Tissue-Removing Element having Oblique Distal End Face |
US17/711,522 | 2022-04-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022219528A1 true WO2022219528A1 (en) | 2022-10-20 |
Family
ID=81346302
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2022/053424 WO2022219528A1 (en) | 2021-04-12 | 2022-04-12 | Tissue removing catheter with tissue-removing element having oblique distal end face |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2022219528A1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070088230A1 (en) * | 2005-09-06 | 2007-04-19 | Fmd Co., Ltd | Medical instrument and medical equipment for treatment, and rotational handle device |
WO2010087910A1 (en) * | 2009-02-02 | 2010-08-05 | Cardiovascular Systems, Inc. | Multi-material abrading head for atherectomy devices having laterally displaced center of mass |
EP2941209A1 (en) * | 2013-01-07 | 2015-11-11 | Taryag Medical Ltd. | Expandable atherectomy device |
US20180317952A1 (en) * | 2017-05-03 | 2018-11-08 | Medtronic Vascular, Inc. | Tissue-removing catheter with guidewire isolation liner |
US20200078038A1 (en) * | 2018-09-10 | 2020-03-12 | Medtronic Vascular, Inc. | Tissue-removing catheter with guidewire detection sensor |
EP3679878A1 (en) * | 2014-12-30 | 2020-07-15 | Bard Peripheral Vascular | Abrasive elements for rotational atherectomy systems |
-
2022
- 2022-04-12 WO PCT/IB2022/053424 patent/WO2022219528A1/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070088230A1 (en) * | 2005-09-06 | 2007-04-19 | Fmd Co., Ltd | Medical instrument and medical equipment for treatment, and rotational handle device |
WO2010087910A1 (en) * | 2009-02-02 | 2010-08-05 | Cardiovascular Systems, Inc. | Multi-material abrading head for atherectomy devices having laterally displaced center of mass |
EP2941209A1 (en) * | 2013-01-07 | 2015-11-11 | Taryag Medical Ltd. | Expandable atherectomy device |
EP3679878A1 (en) * | 2014-12-30 | 2020-07-15 | Bard Peripheral Vascular | Abrasive elements for rotational atherectomy systems |
US20180317952A1 (en) * | 2017-05-03 | 2018-11-08 | Medtronic Vascular, Inc. | Tissue-removing catheter with guidewire isolation liner |
US20200078038A1 (en) * | 2018-09-10 | 2020-03-12 | Medtronic Vascular, Inc. | Tissue-removing catheter with guidewire detection sensor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US12114887B2 (en) | Tissue-removing catheter with guidewire isolation liner | |
US8496680B2 (en) | Guidewire for crossing occlusions or stenoses | |
EP3849442B1 (en) | Tissue-removing catheter with guidewire detection sensor | |
US20150080795A1 (en) | Devices, systems and methods for performing atherectomy and subsequent balloon angioplasty without exchanging devices | |
US20220323098A1 (en) | Tissue Removing Catheter with Tissue-Removing Element having Oblique Distal End Face | |
WO2022219528A1 (en) | Tissue removing catheter with tissue-removing element having oblique distal end face | |
US11690645B2 (en) | Tissue-removing catheter | |
US20250009380A1 (en) | Tissue-removing cathether with flexible distal tip | |
CA2488588C (en) | Guidewire for crossing occlusions or stenosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22717920 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2022717920 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2022717920 Country of ref document: EP Effective date: 20231113 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202280036985.6 Country of ref document: CN |